Company
Zur Rose Group AG
Headquarters: Frauenfeld, Switzerland
Employees: 1,960
CEO: Mr. Walter Oberhänsli
Market Cap
CHF404.5 Million
CHF as of July 1, 2024
US$448.1 Million
Zur Rose Group AG Categories
Switzerland Healthcare Pharmaceutical RetailersSwitzerland Healthcare Switzerland Pharmaceutical Retailers
Top Competitors by Market Capitalization
Industry: Pharmaceutical Retailers
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $450.89 B |
| Johnson & Johnson | $350.63 B |
| Merck | $318.75 B |
Detailed Description
Zur Rose Group AG operates an e-commerce pharmacy and a wholesale business for medical and pharmaceutical products under the Zur Rose and DocMorris brands in Germany, Switzerland, and rest of Europe. It offers consumer health, beauty, and personal care products. The company also provides medicines management services. It operates stationary pharmacy shops. The company sells its products directly to physicians, online mail-order pharmacies, and private individuals. The company was formerly known as Zur Rose AG and changed its name to Zur Rose Group AG in May 2015. Zur Rose Group AG was founded in 1993 and is headquartered in Frauenfeld, Switzerland.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Stocks & Indices
Zur Rose Group AG has the following listings and related stock indices.
Stock: SIX: ROSE wb_incandescent
Stock: OTC: ZRSEF wb_incandescent